|
28.08.25 - 16:48
|
What′s happening to the BP share price? (Fool)
|
|
After a rough year the BP share price is showing signs of life but Harvey Jones is struggling to see where the FTSE 100 dividend growth giant can go from here.
The post What's happening to the BP share price? appeared first on The Motley Fool UK....
|
|
28.08.25 - 08:45
|
BP Neutral (DPA-AFX)
|
|
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat BP mit einem Kursziel von 440 Pence auf "Neutral" belassen. Die strategische Neuaufstellung stehe bei BP im Fokus, schrieb Matthew Lofting in einer am Donnerstag vorliegenden Bewertung zum Ölsektor ......
|
|
|
|
27.08.25 - 14:36
|
Where might the BP share price go from here? (Fool)
|
|
BP's share price performance over the past five years seems strong at first glance. Taking a wider viewpoint though, is this writer ready to invest?
The post Where might the BP share price go from here? appeared first on The Motley Fool UK....
|
|
|
|
|
26.08.25 - 13:03
|
Baker Hughes Awarded Long-Term Service Agreement by bp for Tangguh LNG Operations, Supporting Indonesia′s Energy Future (GlobeNewswire EN)
|
|
HOUSTON and LONDON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology company, announced Tuesday a long-term service agreement award from bp for its Tangguh Liquefied Natural Gas (LNG) plant in Papua Barat, Indonesia. This comprehensive 90-month agreement covers spare parts, repair services, and field service engineering support for critical turbomachinery at the facility including heavy-duty gas turbines, steam turbines, and compressors for three LNG trains, helping to ensure its continued reliable operation. The agreement underscores Baker Hughes' role as a solutions provider....
|
|
26.08.25 - 13:03
|
Medical Affairs Leader Dr. Kirk Shepard Joins BP Logix′s Life Sciences Strategic Advisory Board (Business Wire)
|
|
Renowned Medical Affairs executive and MAPS co-founder Dr. Kirk Shepard steps up to help guide the next wave of digital innovation in the life sciences sector.SAN DIEGO--(BUSINESS WIRE)--#MedicalAffairs--As part of its mission to drive innovation in Medical Affairs automation, BP Logix is pleased to announce the appointment of Dr. Kirk Shepard to the company's Life Sciences Strategic Advisory Board.
Dr. Shepard is a globally recognized expert in Medical Affairs who brings more than 30 years of deep operational knowledge and thought leadership to the Advisory Board.
He currently serves as Chief Medical Officer at PDS Biotech. His prior roles include Chief Medical Officer and Head of Global Medical Affairs Oncology at Eisai, as well as senior leadership positions at Takeda, Boehringer Ingelheim, Baxter, and Baxalta.
He is also a co-founder and former President of the Medical Affairs Professional Society (MAPS), which boasts more than 15,000 members. His upcoming book, Voices of Oncology (Forbes Books, Sept...
|
|
26.08.25 - 10:57
|
BP Aktie: Warum der britische Öl-Konzern trotz Gewinnrückgang Chancen bietet (Aktiencheck)
|
|
Wien (www.aktiencheck.de) - BP-Aktienanalyse von der Raiffeisen Bank International AG:
Aaron Alber, Analyst der Raiffeisen Bank International AG (RBI), stuft die Aktie von BP plc (ISIN: GB0007980591, WKN: 850517, Ticker-Symbol: BPE5, London Stock Exchange-Symbol: BP, NASDAQ OTC-Symbol: BPAQF) in einer aktuellen Aktienanalyse von "Halten" auf "Verkauf" herab. [mehr]...
|
|
|
22.08.25 - 07:51
|
BP: Und es geht weiter (Der Aktionaer)
|
|
So etwas gibt es selten: Schwere Überschwemmungen nach einem Gewitter haben am Montag dafür gesorgt, dass der Energieriese BP den Betrieb in seiner Whiting-Raffinerie im US-Bundesstaat Indiana unterbrechen musste....
|
|
|
|
|
|
|
|
|